-Contracts with Evonik and CoreRx for the manufact
Post# of 72440
-European patent granted for B-OM
-Additional US patent expansion for B
-Non-binding term sheet signed for B-OM and IBD
-EOP2 Meeting and FDA approval for B-OM move to Phase III
I would say that IPIX management have been quite busy.